This article was added by the user . TheWorldNews is not responsible for the content of the platform.

FDA investigating another sudden infant death that may be related to Abbott's infant formula

The US Food and Drug Administration (FDA) launched an investigation on Wednesday by Abbott Laboratories' ABT.N infant formula and distributors.

Abbott began recallinginfant formulain February after a seriousbacterial infectionwas reported in four infants. The Michigan plant was closed and the shortage was exacerbated. Among multiple manufacturers that started with a pandemic supply chain problem.

Breastfeeding banks concerned about the effects of infant formula – May 30, 2022

 FDA Previously, nine infant deaths were reported, two of which were associated with a Michigan botanical survey. Health agencies added that the study could not establish or rule out a direct link between deaths and factory-produced prescriptions.

Trend Story

Story follows below the ad

Abbott on Thursday, Now, when the FDA notified the company last week, it added that the clinical and product information provided was limited, and evidence suggesting a link between death and its infant formula.

The company said it would investigate further when additional data became available.
(Report by Amruta Khandekar; Edited by Shounak Dasgupta)

© 2022 Reuters